These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 15728816)
21. A simple fluorogenic method to detect Vibrio cholerae and Aeromonas hydrophila in well water for areas impacted by catastrophic disasters. Richards GP; Watson MA Am J Trop Med Hyg; 2006 Sep; 75(3):516-21. PubMed ID: 16968933 [TBL] [Abstract][Full Text] [Related]
25. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains. García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073 [No Abstract] [Full Text] [Related]
26. [Current problems of epidemiology and prevention of El Tor cholera]. Teodorovici G Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):1-7. PubMed ID: 5552559 [No Abstract] [Full Text] [Related]
27. [The current status of research on a cholera vaccine]. Fournier JM Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):412-5. PubMed ID: 10078377 [TBL] [Abstract][Full Text] [Related]
28. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR. Viret JF; Dietrich G; Favre D Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410 [TBL] [Abstract][Full Text] [Related]
29. Cholera antibody response in immunized persons in a cholera free area. II. Vibriocidal antibodies. Chirescu N; Năcescu N; Ciufecu C Arch Roum Pathol Exp Microbiol; 1974 Jun; 33(2):149-53. PubMed ID: 4412422 [No Abstract] [Full Text] [Related]
30. [Genetic, molecular, and immunologic aspects of Vibrio cholerae infection]. Fica AE; Cabello FC Rev Med Chil; 1993 Mar; 121(3):312-20. PubMed ID: 8248646 [TBL] [Abstract][Full Text] [Related]
32. A new trend in cholera epidemiology. Mukerjee S; Basu S; Bhattacharya P Br Med J; 1965 Oct; 2(5466):837-9. PubMed ID: 5318298 [No Abstract] [Full Text] [Related]
33. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate. Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477 [TBL] [Abstract][Full Text] [Related]
34. Cholera - recommendations for prevention in travellers. Neilson AA; Mayer CA Aust Fam Physician; 2010 Apr; 39(4):220-6. PubMed ID: 20372681 [TBL] [Abstract][Full Text] [Related]
35. Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638. Talavera A; Año G; García H; Moreira T; Delgado H; Riverón L; Gil S; Miranda A; Cedré B; Valmaseda T; Pino Y; Pérez JL; Infante JF; García L; Sierra G Vaccine; 2006 May; 24(18):3746-9. PubMed ID: 16085342 [TBL] [Abstract][Full Text] [Related]
36. Vaccines for the future: problems and potential solutions from the countries that need them. Jones T; Badaró R Braz J Infect Dis; 2000 Jun; 4(3):156-60. PubMed ID: 10934500 [No Abstract] [Full Text] [Related]
37. Efficacy of a live oral cholera vaccine in human volunteers. Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960 [TBL] [Abstract][Full Text] [Related]
38. [The new ("El Tor") cholera pandemic. Epidemiology, clinical aspects, possibilities of immunoprophylaxis]. Raettig H Munch Med Wochenschr; 1965 Oct; 107(44):2153-8. PubMed ID: 5899032 [No Abstract] [Full Text] [Related]
39. Revitalizing control efforts for cholera. Wkly Epidemiol Rec; 2015 Oct; 90(40):530-4. PubMed ID: 26433980 [No Abstract] [Full Text] [Related]